NuVasive

$57.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-0.09%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NuVasive and other stocks, options, and ETFs commission-free!

About NUVA

NuVasive, Inc. engages in the development of minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. It offers cervical and spine fusion surgery, cervical plating, and posterior fixation products. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA. The listed name for NUVA is NuVasive, Inc. Common Stock.

CEO

J. Christopher Barry

Employees

2,800

Headquarters

San Diego, California

Founded

1997

Market Cap

2.91B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

816.72K

High Today

$58.58

Low Today

$55.78

Open Price

$56.39

Volume

809.79K

52 Week High

$81.00

52 Week Low

$28.55

Collections

Analyst Ratings

42%

of 19 ratings

Buy

42%

Hold

42%

Sell

16%

NUVA Earnings

-$0.52

-$0.10

$0.31

$0.73

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 18, After Hours